BOOM! Studios has released a first look at the upcoming WWE: NXT Takeover – The Blueprint #1, part of a weekly NXT event replacing WWE's comic at the publisher for September. The details on the book: ...
With two new deals Thursday, Blueprint Medicines is “converting future revenue to cash," as CEO Kate Haviland put it. The Massachusetts biotech is selling certain royalties to its targeted cancer ...
Blueprint Medicines is revising a pact with VantAI again, this time adding a focus for historically “undruggable” targets and prioritizing new target-effector pairs that could be used to develop ...
GeekWire chronicles the Pacific Northwest startup scene. Sign up for our weekly startup newsletter, and check out the GeekWire funding tracker and VC directory. by Nat Levy on Nov 21, 2016 at 10:59 am ...
PARIS and CAMBRIDGE, Mass., June 2, 2025 /PRNewswire/ -- Sanofi and Blueprint Medicines Corporation (Blueprint), a US-based, publicly traded biopharmaceutical company specializing in systemic ...
The superstars of NXT are getting their very own series from BOOM! Studios and we’ve got your exclusive first look. The new WWE: NXT Takeover series will feature current stars of WWE’s NXT brand, ...